← Back to all trials
Recruiting
NCT07769489
Study to Assess Tolerability of Injecting Larger Volumes (2-5 mL) Subcutaneously at Different Rates: Participant Experience and Acceptance
Conditions: Healthy Participants
Sex: All
Ages: 18 Years – 64 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 100
Sponsor: Novo Nordisk A/S
Location: Novo Nordisk Clinical Innovation Centre A/S Gentofte Municipality
Summary
The purpose of the study is to investigate the tolerability of different injection/infusion volumes and speed compared to standard practise. The order in which the different volumes and injection speeds will be given to participants will be allocated by chance. Participants will be in this clinical study for about 1 week.
Eligibility Criteria
Inclusion criteria:
* Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study.
* Healthy male or female participants as judged by the investigator.
* Age 18-64 years (both inclusive) at the time of signing the informed consent.
* Body Mass Index (BMI) greater than or equal to (\>=) 18.5 and less than or equal to (\
Source: ClinicalTrials.gov (NCT07769489). StuddyBuddy aggregates publicly available trial information.
